[go: up one dir, main page]

US20080311211A1 - Easily Dispersible Lipidic Phase - Google Patents

Easily Dispersible Lipidic Phase Download PDF

Info

Publication number
US20080311211A1
US20080311211A1 US12/094,682 US9468206A US2008311211A1 US 20080311211 A1 US20080311211 A1 US 20080311211A1 US 9468206 A US9468206 A US 9468206A US 2008311211 A1 US2008311211 A1 US 2008311211A1
Authority
US
United States
Prior art keywords
oil
lpa
peg
phase
lipidic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/094,682
Other languages
English (en)
Inventor
Martin Leser
Laurent Sagalowicz
Martin Michel
Philippe Frossard
Corinne Appolonia-Nouzille
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Nestec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA filed Critical Nestec SA
Assigned to NESTEC S.A. reassignment NESTEC S.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: APPOLONIA-NOUZILLE, CORINNE, FROSSARD, PHILIPPE, MICHEL, MARTIN, SAGALOWICZ, LAURENT, LESER, MARTIN
Publication of US20080311211A1 publication Critical patent/US20080311211A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01—Other fatty acid esters, e.g. phosphatides
    • A23D7/011—Compositions other than spreads
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/42—Ethers, e.g. polyglycol ethers of alcohols or phenols

Definitions

  • the invention relates to a lipidic phase comprising an oil and a lipophilic additive (LPA), which is suitable to make an oil-in-water emulsion by application of low energy or a manual operation.
  • LPA lipophilic additive
  • Lipid phases such as oils or fats are common ingredients used in many different products.
  • the bulk lipid phase In order to give the lipid phase containing products an acceptable physical homogeneity and ‘shelf-life’ (oil and water do not mix with each other) the bulk lipid phase has to be broken up into small droplets, i.e. the lipid phase has to be dispersed into an aqueous continuous phase.
  • the obtained product is an oil-in-water emulsion.
  • the dispersed oil droplets are stabilised by surface active molecules which form a stabilization layer around the oil droplets.
  • Both oil-in-water and water-in-oil emulsions can be formulated depending on the solubility of the used surface active molecules (also denoted as emulsifiers) which stabilize the dispersed phase droplets.
  • surface active molecules also denoted as emulsifiers
  • Oil-in-water emulsions are stabilized by hydrophilic surface active molecules, whereas water-in-oil emulsions are stabilized by lipophilic emulsifiers.
  • the oil phase has to be dispersed as small oil droplets having a radius from ca 100 nm up to several hundreds of micrometers, into the continuous aqueous phase.
  • homogenisers i.e. machines which are able to add high energy to the oil-water mixture are necessary to use.
  • the formation of the stabilization layer around the oil droplets during the homogenisation step renders the oil droplets kinetically stable against coalescence, flocculation, coagulation, Ostwald ripening or creaming.
  • the surface active material used in oil-in-water based emulsion products can either be low molecular weight hydrophilic surfactants, such as polysorbates, lysolecithins, etc., or polymers, such as proteins, e.g. gelatin or from milk, soya, or polysaccharides, such as gum arabic or xanthan, or (nano or micro)-particles, such as silica particles, or mixtures thereof.
  • hydrophilic surfactants such as polysorbates, lysolecithins, etc.
  • polymers such as proteins, e.g. gelatin or from milk, soya, or polysaccharides, such as gum arabic or xanthan, or (nano or micro)-particles, such as silica particles, or mixtures thereof.
  • Oil-in-water emulsion based products are ubiquitous in—Food, Cosmetics, Pharmaceuticals or Agro-chemicals.
  • Prominent oil-in-water emulsion-based food products are for instance milk, mayonnaise, salad dressings, sauces or clinical products.
  • Prominent oil-in-water emulsion-based products used in the cosmetical or pharmaceutical Industry are lotions, creams, milks, pills, tablets, dragees etc.
  • the oil droplets in such products are usually made of lipids, for instance, triglycerides, diglycerides, waxes, fatty acid esters, fatty acids, alcohols, mineral oils, or hydrocarbons.
  • Emulsions are used either as a starting material, intermediate or final product or as an additive to a final product.
  • emulsions in Industry are to deliver active compounds or functional molecules, such as, flavours, vitamins, antioxidants, nutraceuticals, phytochemicals, drugs, chemicals, etc.
  • Administration of the active components requires the use of an appropriate vehicle for bringing an effective amount of the active component into the product and/or desired place of action.
  • Oil-in-water emulsions are commonly used delivery systems since they take advantage of the increased solubility of lipophilic active compounds in the oil with respect to water.
  • a hydrophobic active ingredient such as a flavour component
  • a hydrophobic active ingredient is mixed into a matrix via an extruder in form of an oil-in-water emulsion in order to increase the stability of the introduced active ingredient during further processing of the product.
  • WO 00/59475 as an example for a pharmaceutical oil-in-water emulsion, a composition and method for improved delivery of ionizable hydrophobic therapeutic agents is described, which are mixed together with an ionizing agent, a surfactant and a triglyceride to form an oil-in-water emulsion.
  • WO 99/63841 as an example for the use of emulsions in the food area, describes compositions comprising phytosterol having enhanced solubility and dispersibility in an aqueous phase due to the formation of an emulsion or a microemulsion.
  • Another reason to disperse a lipid into an aqueous phase in form of an emulsion is to create a homogeneous and kinetically stabilized oil and water containing product.
  • This is a need in the manufacture of a great variety of different products: For instance, in ice cream production during the preparation of the ice cream mix before freezing, in the production of mayonnaise, sauces, dressings, creams, lotions, sprays and in lots of more oil containing products in which a lipid phase has to be incorporated into an aqueous continuous phase to obtain a kinetically stable and homogeneous intermediate or end product.
  • the so prepared products have the disadvantage that they have only a limited storage stability, since the lipid phase is distributed in the product in a inhomogeneous way leading quickly to extensive phase separation after preparation.
  • This sort of instability or inhomogeneity in the prepared product is mainly observed when the Instant products contain oil or other lipidic components. Therefore, the word ‘inhomogeneity’ describes the fact that the oil phase is not distributed in a homogeneous, i.e., uniform, way throughout the product. This situation can be easily visualized by light microscopy, which allows to localize the oil/fat due to specific oil coloration technology. If the oil inhomogeneity is quite significant, non-dispersed macroscopic oil patches can be observed also by eye.
  • oil-based ingredients show insufficient dispersion properties when added to water or water based products without applying a high energy process.
  • Manual operation generally is not sufficient to get a stable product, therefore, leading to the formation of very heterogeneous emulsions that quickly phase separate and physically destabilize.
  • the inhomogeneity of the oil containing product is due to the fact that the created emulsion droplets are very large (hundreds of microns) and polydisperse when using low energy mixing.
  • the final product in this case is a water-in-oil emulsion.
  • the mix consists of a mixture of a hard fat, an oil and a water-in-oil emulsifier, which is added to the oil/fat phase to stabilize the water phase which is added by the consumer during in home preparation of the butter-substitute using a conventional home mixer to form a water-in-oil emulsion.
  • These products are quite unstable when stored at room temperature and have to be refrigerated to improve the product stability.
  • WO 03/053149 A1 discloses a method for the preparation of a spreadable oil and water emulsion comprising mixing a base composition with oil and/or water by a simple manual operation.
  • the base composition comprises a cold hydrating viscosifying agent, such as the cold hydrating starch or a polysaccharide, a hydrophilic emulsifier, such as hydrolysed lecithin, or caseinate or a caseinate replacer, and optionally an acidifying agent.
  • the presence of the viscosifying agent, especially the polysaccharide in the base composition leads to products with smaller average oil droplet size in a final oil-in-water emulsion.
  • oil droplets in the oil-in-water emulsions are ultra small, e.g. in the order of several manometers to about 200 nm diameter, and spontaneously formed (without the use of a high energy intake device) the emulsion is called an ‘oil-in-water microemulsion’ (Evans, D. F.; Wennerström, H. (Eds.); ‘The Colloidal Domain’, Wiley-VCH, New York, (1999)).
  • These emulsions are clear and thermodynamically stable and, therefore, are for the man skilled in the art different from ordinary emulsions the latter being thermodynamically unstable and generally turbid.
  • JP 2004 008837 discloses an oil in water emulsion which contains water-soluble solid particles present in the oil droplets.
  • the particles are in the size range of 20 nm to 10 ⁇ m.
  • the particles are prepared in a water-in-oil (w/o) emulsion by means of dehydration (i.e., not a spontaneous process) before the whole particle/oil (S/O) suspension is dispersed in an aqueous phase using the porous membrane emulsification process.
  • WO 02/076441 discloses the use of an alcohol-in-fluorocarbon microemulsion as a precursor for the preparation of solid nanoparticles.
  • the nanoparticles have a diameter below 200-300 manometers. Nanoparticle formation is not spontaneous and triggered by cooling the precursor microemulsion below about 35° C., or by evaporating the alcohol in the precursor microemulsion or by diluting the microemulsion with a suitable polar solvent.
  • US 2004/022861 discloses a w/o/w double emulsion, in which the oil droplets containing an aqueous microscopic water phase containing protein or another hydrophilic agent.
  • the whole double emulsion is sprayed into, for instance, liquid nitrogen via a capillary nozzle for production of protein-loaded microparticles.
  • a low energy device can be also selected from methods allowing to form oil droplets using membrane emulsification, nano-and microfluidics devices or static mixers.
  • the lipidic phase used for making the emulsion of this invention is easy to prepare and does not need sophisticated mixing equipment.
  • the present invention is based on the finding of novel nano-sized self-assembled structures in the interior of ordinary oil droplets when the oil phase contains a lipophilic additive (LPA).
  • the structures inside the droplets are thermodynamically stable and stabilized by the lipophilic additive (LPA).
  • LPA lipophilic additive
  • a lipidic phase which consists of an oil or fat and a lipidic additive, is defined from which an oil-in-water emulsion, comprising oil droplets having a nano-sized self-assembled internal structures, is made.
  • the presence of the nano-sized self-assembled structures inside the oil phase is responsible for the significant reduction of the interfacial tension established between the aqueous and the lipidic phase measured with a common drop shape analysis tensiometer.
  • the measured interfacial tension between the aqueous phase (containing no additional emulsifier) or normal tap water and the lipidic phase of this invention is between 1-5 mN/m when measured after an adsorption time which is not longer than 10 to 100 seconds.
  • the respective interfacial tension between water and oil in the absence of an added LPA in a triglyceride oil phase has been measured to be between 6 and 30 mN/m at room temperature, depending on the degree of purity of the used oil and the salt content in the aqueous phase (no emulsifier or surfactant added).
  • the break-up of the oil into small and homogeneous droplets is significantly facilitated without using a high energy intake device.
  • this time is called also the ‘life time’ of the oil droplet immersed in the water phase
  • the break-up of the oil into small and homogeneous droplets is significantly facilitated without using a high energy intake device.
  • a hydrophilic emulsifier is added to the system. In this way stable and homogeneous emulsions can be produced just using low energy or performing a manual operation.
  • High shear homogenisers are superfluous in this case.
  • a lipophilic additive such as the monoglyceride
  • This lower lipophilic additive concentration limit depends on the chemical structure of both the LPA and oil an can be as low as 0.1% LPA on the oil phase.
  • the characteristic low interfacial tension measured between the lipidic phase of the present invention and an aqueous phase can only be quantified in the absence of extra hydrophilic amphiphilic molecules, surfactants or emulsifiers in the water phase. In this case it can easily be measured and monitored by means of standard tensiometers, such as a Pendant Drop tensiometer (example the TRACKER tensiometer from Teclis-ITConcept from France, of the PAT tensiometer from SINTERFACE Technologies from Berlin, Germany) or a drop volume tensiometer (example the TVT 2 from Lauda, Germany).
  • a Pendant Drop tensiometer example the TRACKER tensiometer from Teclis-ITConcept from France, of the PAT tensiometer from SINTERFACE Technologies from Berlin, Germany
  • a drop volume tensiometer example the TVT 2 from Lauda, Germany.
  • the measurements are done in the absence of any additional hydrophilic emulsifier, since adding an additional hydrophilic emulsifier into the aqueous phase, would disturb the measurements. The extra emulsifier would also adsorb to the interface and decrease the measured interfacial tension.
  • the hydrophilic emulsifier is needed in order to make the produced emulsion droplets stable against coalescence.
  • the homogeneity of the obtained emulsions of this invention is also reflected in the relatively low measured mean oil droplet size.
  • preparing an emulsion of this invention containing 40% soybean oil and 1-10% DIMODAN U/J (the LPA) calculated on the total lipidic phase, and 60% of an aqueous 5 wt-% Na caseinate solution by using a propeller mixer produced oil droplets which are 2-4 times smaller than the emulsion droplets which do not contain DIMODAN U/J, respectively.
  • the oil-in-water emulsion is made by using a 2-chamber assembly.
  • This 2-chamber assembly allows to store separately the lipidic and aqueous phase of the invention before mixing.
  • the assembly contains at its exit means which allow to mix the lipidic and hydrophilic phase to produce the oil-in-water emulsion of the invention.
  • the low energy mixing device can be a static mixer which is fixed at the end of the assembly. When pressing the lipidic and aqueous phases downwards the phases pass through the low energy mixing device and the emulsion is formed.
  • the oil-in-water emulsion is made by pressing a pre-emulsion of the lipophilic and aqueous phase through a static mixer in order to produce the homogeneous and stable oil-in-water emulsion of this invention.
  • the homogeneous emulsion of this invention can also be formed by simply shaking or compressing a pouch which contains the lipidic phase of this invention and an aqueous phase.
  • Such emulsion products are used, for instance, in clinical or enteral nutrition for tube feeding applications, where the mechanical forces for mixing the instable oil-water mixture are usually very low.
  • the oil-in-water emulsion is made by dissolving the respective emulsion in form of a powder into cold water.
  • the oil, containing the lipophilic additive is easily dispersed and powder material easily reconstituted by, for instance, stirring with a spoon at room temperature or temperatures below 25° C. leading to a homogeneous, and stable oil-in-water emulsion.
  • the formed oil droplets exhibit a nano-sized self-assembled structure in their interior.
  • This internal oil droplet structure is formed by the presence of the lipophilic additive (LPA) and mainly consists of nano-sized and thermodynamically stable hydrophilic domains, i.e., water droplets, rods or channels.
  • the nano-sized domains which are formed spontaneously (thermodynamically driven) inside the emulsion oil droplets, are stabilized by the LPA.
  • the lipophilic additive (LPA) has a slight amphiphilic character, i.e., it contains a hydrophilic head group and a lipohilic chain.
  • the hydrophilic part of the LPA molecule is part of the hydrophilic domain structure.
  • the hydrophilic domains can be of the size of 0.5 to 200 nm of diameter, preferably in the range of 0.5 to 150 nm of diameter, even more preferably in the range of 0.5 to 100 nm of diameter, and most preferably in the range of 0.5 to 50 nm.
  • the size of the hydrophilic domains critically depends on the amount of LPA added to the oil droplets and on the type (chemical structure) of the used oil. The spontaneous formation of the nano-sized self-assembled structure inside the oil droplets is independent on the energy intake, used to make the emulsion.
  • the ‘hydrophilic domain’ consists of the water domains and the hydrophilic headgroup area of the LPA molecules. Due to their ultra-small size, they also exhibit a large surface area which is a suitable location for the solubilization of a variety of different compounds.
  • w/o/w (water/oil/water) double emulsions are oil-in-water emulsions, in which the oil droplets contain micron-sized water droplets (Garti, N.; Bisperink, C.; Curr. Opinion in Colloid & Interface Science (1998), 3, 657-667).
  • the water droplets inside the dispersed double emulsion oil droplets are prepared (dispersed) by mechanical energy input, e.g., homogenisation, and, as a consequence, are thermodynamically unstable and not self-assembled.
  • the diameter of the inner water droplets in a w/o/w double emulsion are larger than 300 nm diameter.
  • the emulsions of this invention can easily be distinguished from ordinary w/o/w double emulsions since the formation of the nano-sized self-assembled structure inside the oil droplets of the emulsion of this invention is spontaneous and thermodynamically driven, and the mean diameter of the water droplets or channels is below 200 nm.
  • the invention is directed towards oil droplets which contain a nano-sized self-assembled structure with hydrophilic domains.
  • the oil droplets are formed by applying low energy or a manual operation.
  • self-assembly or ‘self-organization’ refers to the spontaneous formation of aggregates (associates) or nano-structures by separate molecules. Molecules in self-assembled structures find their appropriate location based solely on their structural and chemical properties due to given intermolecular forces, such as hydrophobic, hydration or electrostatic forces (Evans, D. F.; Wennerström, H. (Eds.); ‘The Colloidal Domain’, Wiley-VCH, New York, (1999)).
  • the result of self-assembly does not depend on the process itself and corresponds to a state of minimum energy (stable equilibrium) of the system.
  • the present invention concerns the use of a lipidic phase comprising an oil and a lipophilic additive (LPA) for preparing an oil-in-water emulsion wherein the LPA content in the lipidic phase is comprised between 0.25-wt-% and 84 wt-%.
  • the LPA content is comprised between 2.5 wt-% and 80 wt-%.
  • said LPA content is comprised between 5 wt-% and 80 wt-%.
  • Even most preferably the LPA content is between 10 wt-% and 80 wt-%, and wherein the aqueous phase contains a hydrophilic emulsifier and wherein both phases are mixed.
  • the interfacial tension between the lipidic phase of the invention and an aqueous phase which contains no hydrophilic emulsifiers is below 5 mN/m when measured upto 100 seconds or shorter.
  • the present invention concerns the use of a lipidic phase wherein the mixing of lipidic and aqueous phases is made by using a manual operation or a low energy device.
  • Another object of the invention is to provide an assembly, comprising a pre-mix of the lipidic phase of the invention and an aqueous phase containing a hydrophilic emulsifier in a container and comprising further means for preparing the oil-in-water emulsion of the invention.
  • Another object is to provide an assembly, comprising a lipidic phase which is separated from an aqueous phase containing a hydrophilic emulsifier in a container, with an exit comprising means for mixing both phases and preparing the oil-in-water emulsion of the invention.
  • Another object is to provide an assembly comprising a lipidic and an aqueous phase containing a hydrophilic emulsifier, where both phases are in a flexible pouch.
  • Another object is to provide an oil-in-water emulsion comprising a lipidic and an aqueous phase containing a hydrophilic emulsifier, wherein the means are selected from the group consisting of manual squeezing, magnetic stirring, hand shaking, spoon or whisk stirring, vortex mixing, membrane emulsification, static mixer, kitchen mixer, nano-and microfluidics devices, pouch mixing or any mixer which creates a turbulent flow, or combinations thereof.
  • the present invention concerns also a lipidic phase which after low energy mixing with an aqueous phase gives an oil-in-water emulsion, wherein the oil droplets exhibit a nano-sized structurisation with hydrophilic domains being formed by a lipophilic additive (LPA).
  • LPA lipophilic additive
  • the LPA can be added as such or made in situ by chemical, biochemical, enzymatic or biological means.
  • the amount of oil droplets (oil droplet volume fraction) present in the emulsion of this invention is the amount generally used in ordinary oil-in-water emulsion products.
  • the volume fraction of the lipidic phase can vary from a fraction of a percent ( ⁇ 0.001% on the total product), as is used in therapeutic oil-in-water emulsions, in which the lipidic phase is an expensive drug, nutrient, chemical or another functional lipophilic component, up to 80% (on the total product), as observed in HIPE's (High Internal Phase Emulsions), such as, for instance, full-fat mayonnaise.
  • the present invention is directed to a lipidic phase and its corresponding oil-in-water emulsion comprising dispersed oil droplets having a nano-sized self-assembled structured interior comprising
  • lipidic phase refers to an oil phase containing a certain amount of a ‘lipophilic additive’.
  • the oil phase can be also partially crystallized fat, such as hardened palm oil, hardened palm kernel oil, butter fat at the temperature of use.
  • the temperature of emulsion formation can be between 4° C. and 100° C.
  • a ‘lipophilic additive’ refers to a lipophilic amphiphilic agent which spontaneously forms stable nano-sized self-assembled structures in the bulk and dispersed oil phase.
  • the LPA concentration in the oil phase must be larger than the CMC (critical micellar concentration). Below this concentration, no self-assembly structures are formed.
  • the CMC of unsaturated monoglycerides in triglyceride oils is around 2 wt % and 0.1 wt % in squalene or kerosene. (J. Bus et al. Progr Colloids Polymer Sci (1990) 82, 122-130).
  • the CMC critically depends on the molecular structure of the oil and emulsifier, i.e. LPA.
  • the lipophilic additive is selected from the group consisting of fatty acids, sorbitan esters, propylene glycol mono- or diesters, pegylated fatty acids, monoglycerides, derivatives of monoglycerides, diglycerides, pegylated vegetable oils, polyoxyethylene sorbitan esters, phospholipids, cephalins, lipids, sugar esters, sugar ethers, sucrose esters, polyglycerol esters and mixtures thereof.
  • the oil-in-water emulsion exhibits oil droplets having an internal structure taken from the group consisting of the L 2 structure or a combination of a L2 and oil structure (microemulsion or isotropic liquid droplets) in the temperature range of 0° C. to 100° C.
  • the oil-in-water emulsion exhibits oil droplets having a L2 structure (microemulsion or isotropic liquid droplets) in the temperature range of 0° C. to 100° C.
  • L2 structure microemulsion or isotropic liquid droplets
  • the oil-in-water emulsion exhibits oil droplets having an internal structure taken from the group consisting of the L2 structure (microemulsion or isotropic liquid droplets) or reversed micellar cubic structure or reversed bicontinuous L3, and a combination thereof in the temperature range of 0° C. to 100° C.
  • the oil-in-water emulsion exhibits oil droplets having an internal reversed micellar cubic structure in the temperature range of 0° C. to 100° C.
  • the oil-in-water emulsion exhibits oil droplets having an internal reversed hexagonal structure in the temperature range of 0° C. to 100° C.
  • the oil-in-water emulsion exhibits oil droplets having an internal structure which is a combination of the previously described structures in the temperature range of 0° C. to 100° C.
  • temperatures higher than 100° C. for example retorting temperature
  • the use of temperatures higher than 100° C. is also possible and is covered by the present invention.
  • the lipophilic additive can also be mixed with a hydrophilic additive (having a HLB larger than 10) up to the amount that the mixture is not exceeding the overall HLB of the mixture of 10 or preferably 8.
  • the additive can also be made in-situ by chemical, biochemical, enzymatic or biological means.
  • the amount of added lipophilic additive is defined as ⁇ .
  • ⁇ is defined as the ratio LPA/(LPA+oil) ⁇ 100.
  • ⁇ is preferably higher than 0.25, more preferably higher than 0.5, even more preferably higher than 1 and even more preferable higher than 2.
  • the lower and higher limit of ⁇ depends on the properties of the taken oil and LPA, such as the polarity, the molecular weight, dielectric constant, etc., or physical characteristics such as the critical aggregation concentration or critical micellar concentration (CMC) of the LPA in the oil droplet phase.
  • the lower ⁇ limit is generally comparable to or higher than the measured CMC exerted by the used LPA/oil mixture. ‘Comparable to’ means here that ⁇ is >0.2 ⁇ CMC.
  • the emulsion is stabilized by a hydrophilic emulsifier suitable to stabilize ordinary oil-in-water emulsion droplets.
  • the emulsion can be aggregated (flocculated) or not depending on the used emulsifier.
  • the hydrophilic emulsifier is selected from the group consisting of low molecular weight surfactants having a HLB>8, gelatin, proteins from e.g.
  • milk or soya peptides, protein hydrolysates, block co-polymers, surface active hydrocolloids such as gum arabic, xanthan gum, diblockcopolymer- or apoprotein-like biopolymers, such as protein-polysaccaride conjugates or coacervates, or protein-polysaccharide, protein-protein, or polysaccharide-polysaccharide hybrids, conjugates or coacervates or mixtures of polymers and biopolymers, or protein nanoparticles, surfactant-protein nanoparticles or other nano- or micro-particles suitable to stabilize oil-in-water emulsions.
  • surface active hydrocolloids such as gum arabic, xanthan gum, diblockcopolymer- or apoprotein-like biopolymers, such as protein-polysaccaride conjugates or coacervates, or protein-polysaccharide, protein-protein, or polysaccharide-polysaccharide hybrids
  • the hydrophilic emulsifier can also be mixed with the LPA, or with the oil, or with the LPA and the oil. This means, that the hydrophilic emulsifier can partly also be present in the interior of the oil droplet and affecting the internal nano-sized self-assembled structure and the mixing behaviour during the preparation of the emulsion.
  • the ratio ⁇ hydrophilic emulsifier/(LPA+oil+emulsifier) ⁇ 100 describes the amount of emulsifier used to stabilize the oil droplets with respect to the oil plus LPA content.
  • ⁇ is preferably higher than 0.1, more preferably higher than 0.5, more preferably higher than 1, and more preferably higher than 2, and even more preferably higher than 5.
  • active components can be solubilized in the nano-sized self-assembled structured interior of the oil droplets.
  • They can be oil-soluble, oil non-soluble, crystallinic or water soluble components selected from the group consisting of nutraceuticals, such as lutein, lutein esters, ⁇ -carotene, tocopherol, tocopherol acetate, tocotrienol, lycopene, Co-Q 10 , flax seed oil, lipoic acid, vitamin B 12 , vitamin D, ⁇ - and ⁇ -polyunsaturated fatty acids, phytosterols, flavonoids, vitamin A, vitamin C or its derivatives, sugars, food supplements, functional ingredients, food additives, plant extracts, medicaments, drugs, pharmacologically active components, cosmetically active components, peptides, proteins or carbohydrates, aroma, salts and flavours.
  • nutraceuticals such as lutein, lutein esters, ⁇ -carotene, tocopherol, tocopherol acetate
  • the lipophilic additive is selected from the group consisting of myristic acid, oleic acid, lauric acid, stearic acid, palmitic acid, PEG 1-4 stearate, PEG 2-4 oleate, PEG-4 dilaurate, PEG-4 dioleate, PEG-4 distearate, PEG-6 dioleate, PEG-6 distearate, PEG-8-dioleate, PEG-3-16 castor oil, PEG 5-10 hydrogenated castor oil, PEG 6-20 corn oil, PEG 6-20 almond oil, PEG-6 olive oil, PEG-6 peanut oil, PEG-6 palm kernel oil, PEG-6 hydrogenated palm kernel oil, PEG-4 capric/caprylic triglyceride, mono, di, tri, tetraesters of vegetable oil and sorbitol, pentaerythrityl di, tetra stearate, isostearate, oleate, caprylate
  • the lipidic phase according to the invention is normally in liquid or paste form. According to another embodiment of the invention, the lipidic phase is dried and is available in powder form. The powder can be easily reconstituted when added into an aqueous or pure water phase. According to another embodiment of the invention, the lipidic phase can contain other ingredients, such as spices, herbs, or aromas.
  • the lipidic phase according to the invention is either a final product or an additive or intermediate product.
  • the amount of the additive in the final product is not critical and can be varied.
  • the oil-in-water emulsion obtained from the low energy mixing of the lipidic phase of the invention with an aqueous phase according to the invention is either a final product or an additive.
  • the amount of the additive in the final product is not critical and can be varied.
  • the emulsion described in this invention is a novel type of emulsion which we name ‘ISAMULSION’ to describe the specific nature of the oil droplets containing a structure being Internally Self-Assembled, and to exclude the emulsion of this invention from ordinary oil-in-water or w/o/w double emulsions, including nano- and microemulsions, in which the oil droplets do not have a nano-sized self-assembled structure with hydrophilic domains.
  • the ISAMULSION droplets basically consist of oil droplets which have a nano-sized self-assembled structure with hydrophilic domains.
  • This nano-structure is of a reversed nature comprising the L2, the microemulsion, the isotropic liquid phase, the micellar cubic, the hexagonal H2, or the bicontinous L3 or phase.
  • the structures in the oil phase can appear as a single nano-structure or as a mixture of different nano-structures.
  • lipidic phase or a mix containing this lipidic phase which allows to easily prepare an oil-in-water emulsion formulation just by adding low energy to the water-oil mixture.
  • the lipidic phase can be used as such or can be part of a ready-to-use product, which can be used to freshly prepare the emulsion product during cooking or food preparation in the kitchen, restaurants, cantines, during camping or at other comparable occasions where no high shearing device is at one's disposal.
  • the ready-to-use product can be used to freshly prepare a BBQ sauce or other sauces, marinade, mayonnaise, ketchup, salad dressings, seasonings, spices, and similar type of products.
  • lipidic phase or the ready-to-use product containing the lipidic phase of the invention is for the fortification of home-made products with lipidic (non-easy-dispersible) functional molecules, such as nutrients, aromas, taste enhancers etc.
  • FIG. 2 shows a Cryo-TEM micrograph of a typical ISAMULSION, showing the nano-sized hydrophilic domains inside single oil droplets.
  • FIG. 3 shows the small angle X-ray scattering (SAXS) pattern of an ISAMULSION, of the bulk oil phase (nano-structured by LPA), which was used for making the ISAMULSION and of the corresponding ordinary emulsion (without LPA, without nano-structure).
  • SAXS small angle X-ray scattering
  • the content of the LPA determines the concentration and size of the self-assembled hydrophilic domains inside the oil droplets.
  • FIG. 5 shows a schematic of an Isamulsion oil droplet, which contains hydrophilic domains.
  • the hydrophilic domains can be spherical or non-spherical, i.e. rods, disks or channels.
  • the hydrophilic domain consists of the polar head group of the LPA and the solubilized water.
  • FIG. 6 shows the small angle X-ray scattering (SAXS) curve of an ISAMULSION containing oil droplets that have a reversed micellar cubic Fd3m structure.
  • FIG. 7 shows the interfacial tension measured between the lipidic phase of the invention (in this case soybean oil+Dimodan U/J as LPA) against pure water as a function of the DIMODAN U/J content, using the Pendant Drop technique.
  • the lipidic phase of the invention in this case soybean oil+Dimodan U/J as LPA
  • FIG. 8 shows the interfacial tension measured between the lipidic phase of the invention (in this case soybean oil+Dimodan U/J as LPA) against pure water as a function of the DIMODAN U/J content, using the Drop volume tensiometer.
  • the lipidic phase of the invention in this case soybean oil+Dimodan U/J as LPA
  • FIG. 9 shows the oil droplet size D32 (Sauter droplet diameter, given in microns) of ISAMULSIONS as a function of the DIMODAN U/J content in the oil phase, given as wt-% of Dimodan U/J in soybean oil.
  • the ISAMULSION oil phase (soybean+DIMODAN U/J) is constant 40 vol % in all emulsions. Emulsions are stabilized by 5 wt-% Na-Caseinate (on aqueous phase); Emulsions are prepared by using a low energy stirrer. Malvern Mastersizer data FIG.
  • L2 denotes a reversed microemulsion-like structure
  • LC denotes the existence of a liquid crystalline phase or a mixture of different liquid crystalline phases, such as the reversed micellar or reversed hexagonal, or reversed bicontinuous cubic.
  • a defined nano-sized self-assembled structure is formed at a given temperature and a specific amount of added lipophilic additive ( ⁇ value) inside the oil droplets (for a closer description of the mentioned structures, see Evans, D. F.; Wennerström, H. (Eds.); ‘The Colloidal Domain’, Wiley-VCH, New York, (1999)).
  • the amount of added LPA allows to precisely control the type of self-assembly structure, amount of water present in the hydrophilic domains, the amount of internal interface and the size, dimension, of the self-assembly nano-structure formed inside the ISAMULSION droplets.
  • the minimum amount of LPA ( ⁇ ) needed to initiate the spontaneous formation of the self-assembled internal droplet structure (also denoted as critical micellar concentration CMC or critical aggregate concentration) is between 0.1 and 15 wt-% (on the oil phase).
  • the ⁇ value at which a phase change in the oil droplets is observed depends also on the used type of oil and/or lipophilic additive.
  • the internal nano-sized self-assembled structure of the oil droplets in the emulsion can be detected by means of Cryo-Transmission Electron Microscopy or SAXS.
  • the cryo TEM image of FIG. 2 was obtained using the standard technique of Adrian et al (Adrian et al. Nature, (1984) 308, 32-36). A home made guillotine was used for sample freezing. A droplet of 3 ⁇ l sample dispersion was deposited onto a copper grid covered with a holy carbon film containing holes of about 2 ⁇ m in diameter. A filter paper was pressed on the liquid side of the grid (blotting) for removing excess sample solution.
  • FIG. 2 is a Cryo-TEM micrograph of a typical ISAMULSION showing characteristic distances between the bright features of about 7-8 nm. It should be noted that such bright features are not observed for standard non-structured emulsions and there is no contrast inside non-structured emulsion droplets.
  • the SAXS curves of FIG. 3 were obtained by a standard equipment (Bergmann et al. J. Appl. Cryst . (2000) 33, 869-875), using a X-ray generator (Philips, PW 1730/10) operating at 40 kV and 50 mA with a sealed-tube Cu anode.
  • SAXSQuant software Averaged-ray scattering pattern
  • the broad peaks of scattering profiles were desmeared by fitting these data with the Generalized Indirect Fourier Transformation method (Bergmann et al. (2000), 33, 1212-1216).
  • FIG. 3 shows the small angle X-ray scattering patterns of an ISAMULSION (same as investigated in FIG.
  • the ISAMULSION shows the same peak position as the non-dispersed bulk oil phase that it is made from.
  • the characteristic distance for both is about 7.5 nm. This characteristic distance is higher than the diameter of the hydrophilic domain. Therefore the hydrophilic domains have a size smaller than 7 nm. For the man skilled in the art, this small size of the hydrophilic domains demonstrates that the internal structure of the oil droplet is thermodynamically stable.
  • FIG. 5 shows a schematic of an oil droplet which has been nano-structured by addition of a LPA.
  • the structural definition of a hydrophilic domain is specified. Hydrophilic domains include the polar part (head group) of the LPA (and not the hydrocarbon tail region and the water part).
  • the minimum diameter of a hydrophilic domain can be about 0.5 nm which is more or less the cross section of 2 head groups containing no water molecules.
  • the minimum size of the polar part of a lipophilic additive or emulsifier is about 0.2 nm.
  • the diameter of a water molecule is about 0.3 nm.
  • FIGS. 6 and 7 are showing oil-water tension measurements as a function of the LPA (DIMODAN U) content in the oil (soybean oil).
  • FIG. 8 shows the Sauter diameter D32 of emulsions made with low energy intake as a function of the DIMODAN U content in the soybean oil phase.
  • the various embodiments of this invention provide an oil-in-water emulsion in which the dispersed oil droplets exhibit a nano-sized, self-assembled structure of hydrophilic domains due to the presence of a lipophilic additive (LPA).
  • LPA lipophilic additive
  • the presence of the LPA in the oil phase allows to prepare oil-in-water emulsions using only low energy intake mixing.
  • a mineral oil such as tetradecane
  • a mineral oil such as tetradecane
  • Pluronic F127 emulsifier
  • 0.5-4 wt % LPA glycerol monolinoleate
  • the total amount of lipophilic molecules was 4.625 wt % ( ⁇ is between 9 and 80).
  • Ultrasonication was then carried out for 20 minutes.
  • the ISAMULSION character of the emulsions was confirmed by cryo-TEM images and SAXS curves such as the ones of FIG. 2 and FIG. 3-4 .
  • LPA mineral oil
  • an ISAMULSION is not formed when no LPA is present as shown in FIG. 3 (composition 4.625 wt % oil (tetradecan
  • emulsifier Pluronic F127
  • the aqueous solution was slowly added to the lipidic solution while vortexing.
  • the ISAMULSION i.e., droplets having an interior nano-sized self-assembled structure has formed.
  • 0.5-4.5 wt % of soybean oil (on the total emulsion product) was mixed first with 0.5-2.0 wt % LPA (Dimodan U/J, Danisco, Dannmark; on the total emulsion product, 10 ⁇ 80) to prepare the lipidic phase.
  • LPA Limodan U/J, Danisco, Dannmark
  • This mixture was added to 95% water containing 0.375% of the emulsifier (Pluronic F127).
  • the total amount of lipidic phase (oil+LPA; given on the total emulsion product) was 4.625 wt %.
  • the mixture was hand shaken. A homogeneous milky and relatively stable emulsion was formed.
  • the ISAMULSION character of the emulsions was confirmed by cryo-TEM images and SAXS.
  • LPA Limodan U/J, Danisco, Dannmark
  • oil droplets were significantly larger than the droplets in the emulsion of this invention (oil droplets contain a LPA) and the milk was significantly creamed after one week of storage at refrigerated temperatures. Only 50% of the oil droplets in the milk after preparation were smaller than 150 ⁇ m (D32 was 35 ⁇ m). This means that they are more than 3 times larger than the oil droplets in the emulsion of this invention in which the oil contained 60% (on the lipidic phase) of LPA.
  • 40 wt % of this lipidic phase was added to 60% of a 5 wt % Na Caseinate solution.
  • the mixture was stirred with a propeller stirrer.
  • a homogeneous milky and stable oil-in-water emulsion was formed. 50% of the emulsified oil droplets were smaller than 73 ⁇ m, as measured with the Malvern Mastersizer.
  • the measured D32 was 13 ⁇ m (see FIG. 9 ).
  • the emulsion and the oil droplets in the emulsion were still stable after one week storage at refrigerated temperatures.
  • the oil droplets were significantly larger than the droplets in the emulsion of this invention (oil droplets contain the LPA, see FIG. 9 ) and the emulsion was significantly creamed and some free oil was detected at the surface of the solution after one week of storage at refrigerated temperatures.
  • Concerning the oil droplet size in this emulsion 50% of the oil droplets were smaller than 150 ⁇ m after preparation and the D32 was 35 ⁇ m (see FIG. 9 ) i.e., still significantly larger than the respective emulsion of this invention, in which the oil contained 2.5 wt % of LPA (calculated on the oil phase).
  • the smaller mean droplet sizes generated with the ISAMULSION formulation is connected with the lower interfacial tension ⁇ exerted between the lipidic phase (soybean oil plus DIMODAN U/J) and pure water ( ⁇ 5 mN/m) compared to the interfacial tension measured between the oil (no added DIMODAN U/J) and pure water ( ⁇ 5 mN/m) (see FIGS. 7 and 8 ).
  • ISAMULSIONS prepared according to the above mentioned examples can be used as such or as an additive.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Colloid Chemistry (AREA)
  • Edible Oils And Fats (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Fats And Perfumes (AREA)
  • General Preparation And Processing Of Foods (AREA)
US12/094,682 2005-11-22 2006-11-22 Easily Dispersible Lipidic Phase Abandoned US20080311211A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05025405 2005-11-22
EP05025405.1 2005-11-22
PCT/EP2006/068739 WO2007060171A1 (en) 2005-11-22 2006-11-22 Easily dispersible lipidic phase

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/068739 A-371-Of-International WO2007060171A1 (en) 2005-11-22 2006-11-22 Easily dispersible lipidic phase

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/422,288 Division US8388985B2 (en) 2005-11-22 2012-03-16 Easily dispersible lipidic phase

Publications (1)

Publication Number Publication Date
US20080311211A1 true US20080311211A1 (en) 2008-12-18

Family

ID=36499352

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/094,682 Abandoned US20080311211A1 (en) 2005-11-22 2006-11-22 Easily Dispersible Lipidic Phase
US13/422,288 Expired - Fee Related US8388985B2 (en) 2005-11-22 2012-03-16 Easily dispersible lipidic phase

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/422,288 Expired - Fee Related US8388985B2 (en) 2005-11-22 2012-03-16 Easily dispersible lipidic phase

Country Status (10)

Country Link
US (2) US20080311211A1 (ru)
EP (1) EP1956920A1 (ru)
JP (1) JP2009523061A (ru)
CN (1) CN101360424B (ru)
AU (1) AU2006316501A1 (ru)
BR (1) BRPI0618834A2 (ru)
CA (1) CA2629733A1 (ru)
IL (1) IL191373A (ru)
RU (1) RU2417618C2 (ru)
WO (1) WO2007060171A1 (ru)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100068105A1 (en) * 2005-04-26 2010-03-18 Aviza Technology Limited Microfluidic structures and how to make them
WO2013060577A1 (en) 2011-10-25 2013-05-02 Unilever N.V. Edible product and use thereof for increasing bioavailability of micronutrients comprised in vegetables or fruit
US20140377435A1 (en) * 2007-12-13 2014-12-25 Cognis Ip Management Gmbh Lipophilic Antioxidant
CN111182883A (zh) * 2017-10-10 2020-05-19 荷兰联合利华有限公司 具有中和的脂肪酸的纳米乳液及其生产方法
CN112933043A (zh) * 2021-02-24 2021-06-11 石家庄四药有限公司 一种盐酸阿比多尔注射乳剂及其制备方法
US20220054999A1 (en) * 2020-08-21 2022-02-24 China Research Institute Of Daily Chemistry Co.,Ltd High internal phase emulsion stabilized by low content of surfactant and preparation method thereof
US11540984B2 (en) 2018-05-23 2023-01-03 Conopco, Inc. Nanoemulsions and a method for making the same
US20240110099A1 (en) * 2019-10-08 2024-04-04 Kao Corporation Liquid-crystal composition
US11985998B2 (en) 2013-09-13 2024-05-21 N. V. Nutricia Process for preparing infant formula using a static mixer

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2348743T3 (es) 2005-11-22 2010-12-13 Nestec S.A. Emulsion aceite-en-agua y su uso para administrar una funcionalidad.
JP5946990B2 (ja) 2007-08-29 2016-07-06 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 化粧品及び医薬品使用のための精油を含有する糖系界面活性剤マイクロエマルジョン
DE102007056424A1 (de) * 2007-11-23 2009-05-28 Neopharmacie Gmbh Pharmazeutische Zusammensetzung, enthaltend eine Öl/Wasser-Emulsion
MX343966B (es) * 2009-01-15 2016-11-30 M-I L L C * Agentes de limpieza para limpiar pozos perforados y metodos de uso de los mismos.
CN102811802B (zh) * 2010-03-24 2015-06-03 巴斯夫欧洲公司 生产热塑性聚酯的水分散体的方法
US8318233B2 (en) * 2010-03-26 2012-11-27 Corn Products Development Inc Emulsions useful in beverages
CN102933075A (zh) * 2010-05-06 2013-02-13 巴斯夫欧洲公司 包含纳米结构化分散相的农药分散体
MY160829A (en) * 2010-12-13 2017-03-31 Miyoshi Yushi Kk Powdered oil composition and production method thereof, and method of improving the functionality of the oil-in-water emulsion
RU2460511C1 (ru) * 2011-05-23 2012-09-10 Вагинак Львович Ханикян Композиция для получения косметических и лекарственных эмульсий и способ ее получения
FR2986535B1 (fr) * 2012-02-02 2015-07-24 Techme Sarl Produit d'elimination des enduits a base de brais, de goudrons ou de bitumes, sous forme d'une emulsion directe d'un solvant vegetal dans l'eau, son procede de preparation et son utilisation
EP2638810A1 (en) 2012-03-15 2013-09-18 N.V. Nutricia Process for preparing infant formula
US20150099638A1 (en) * 2013-10-07 2015-04-09 Presperse Corporation High internal phase compositions utilizing a gemini surfactant
FR3026918B1 (fr) * 2014-10-13 2018-02-23 Even Sante Industrie Procede d'obtention d'un lait infantile pret a l'emploi et de longue conservation
CN106998744A (zh) * 2014-12-15 2017-08-01 雀巢产品技术援助有限公司 咖啡因的控制释放
JP6801646B2 (ja) * 2015-04-14 2020-12-16 日産化学株式会社 ナノ機能性粒子
WO2018108267A1 (en) * 2016-12-14 2018-06-21 Symrise Ag Delivery system for food additives and its preparation
CN108323747B (zh) * 2017-01-19 2022-03-11 丰益(上海)生物技术研发中心有限公司 一种油脂组合物及其制备方法
JP2018183083A (ja) * 2017-04-25 2018-11-22 株式会社Ｊ−オイルミルズ スチームコンベクションオーブン調理用油脂組成物
CN108208838A (zh) * 2018-03-09 2018-06-29 北京素维生物科技有限公司 一种掩味组合物及其用途
CN110507596A (zh) * 2019-09-29 2019-11-29 华南理工大学 以牛奶为基质的水包油型凝胶状乳化物及其快速制备方法
IT201900018548A1 (it) * 2019-10-11 2021-04-11 Wow Kemical S R L Composizione per la separazione di una miscela oleosa
CN113308020A (zh) * 2021-04-22 2021-08-27 长春工业大学 一种水性抗氧剂乳液及其制备方法和应用
CN113730270B (zh) * 2021-10-08 2022-09-23 广州蝶恋花生物科技有限公司 一种利用d相乳化法制备的具有抗皱功效的纳米乳及其应用
CN118304196B (zh) * 2024-03-25 2024-11-05 广州市泛海精细化工有限公司 含聚甘油-3二硬脂酸酯的复合乳化剂及在护肤品中的应用

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935033A (en) * 1970-07-18 1976-01-27 Siemens Aktiengesellschaft Method of improving the radiation resistance of silicon transistors with a silicon oxide coating
US4160850A (en) * 1975-08-25 1979-07-10 General Mills, Inc. Shelf-stable mix for a spreadable butter-substitute
US4200551A (en) * 1978-11-27 1980-04-29 A. E. Staley Manufacturing Company Cold-water-dispersible lecithin concentrates
US4748028A (en) * 1987-02-18 1988-05-31 Borden, Inc. Aseptic fluid coffee whitener and process for preparing same
US4835002A (en) * 1987-07-10 1989-05-30 Wolf Peter A Microemulsions of oil in water and alcohol
US5160759A (en) * 1989-06-07 1992-11-03 Kao Corporation Edible oil-in-water emulsion
US5607622A (en) * 1992-06-29 1997-03-04 Mikimoto Pharmaceutical Co., Ltd. Oil-in-water cream base
US20020106390A1 (en) * 1998-05-11 2002-08-08 Dietmar Huglin Use of nanodispersions in cosmetic end formulations
US20040013708A1 (en) * 2002-04-10 2004-01-22 Goulson Melanie J. Aqueous dispersible steryl ester compositions
US20040022861A1 (en) * 2001-01-30 2004-02-05 Williams Robert O. Process for production of nanoparticles and microparticles by spray freezing into liquid
US20050191343A1 (en) * 2003-11-26 2005-09-01 Shire Laboratories, Inc. Micellar systems useful for delivery of lipophilic or hydrophobic compounds
US20070213234A1 (en) * 2004-05-18 2007-09-13 Nestec S.A. Oil-in-water emulsion for delivery

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0305314A1 (en) 1987-08-18 1989-03-01 A.B. Chance Company Pultruded or filament wound synthetic resin fuse tube
GB8911878D0 (en) * 1989-05-24 1989-07-12 Allen Nicholas J Mixing device
EP0420315B1 (en) * 1989-05-24 1993-11-03 Unilever N.V. Spread
ES2046005T3 (es) * 1990-05-02 1994-01-16 Unilever Nv Nata no lactea para batir.
JP2720101B2 (ja) * 1990-08-17 1998-02-25 明治乳業株式会社 注射用ｗ／ｏ／ｗ型複合エマルション及びその製造法
CN1179896A (zh) * 1996-09-24 1998-04-29 雀巢制品公司 用于制备含水的巧克力或其类似物的方法
JPH10244139A (ja) * 1997-03-06 1998-09-14 Lion Corp 真空乳化釜における雑菌混入防止方法および無菌真空乳化装置ならびに界面活性剤含有組成物の製造方法
RU2200420C2 (ru) * 1997-05-27 2003-03-20 Сембиосис Джинетикс Инк. Способ получения масляной эмульсии (варианты), эмульсия, препарат для кормления рыб, способ получения масляной эмульсии для местного применения и масляная эмульсия для местного применения
BR9910950A (pt) 1998-06-05 2002-02-13 Forbes Medi Tech Inc Composições compreendendo fitosterol e fitostanol tendo solubilidade e dispersibilidade aumentadas
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
EP1116515A3 (en) 2000-01-11 2002-08-21 Givaudan SA Encapsulated liquid
CA2430286A1 (en) * 2000-11-29 2002-06-06 Taisho Pharmaceutical Co., Ltd. W/o/w composite emulsion
JP2002302414A (ja) * 2000-12-26 2002-10-18 Kokuriyuudou:Kk スフィンゴ脂質構造物質含有乳化組成物及びその製造方法
GB0104698D0 (en) 2001-02-26 2001-04-11 Syngenta Ltd Process for producing microcapsules
WO2002078661A2 (en) 2001-03-20 2002-10-10 The Procter & Gamble Company Oxidizing compositions comprising a phosphonic acid type chelant and a conditioning agent and methods of treating hair
CA2445125A1 (en) * 2001-03-21 2002-10-03 University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
PL200106B1 (pl) * 2001-12-21 2008-12-31 Unilever Nv Wieloprzedziałowy przyrząd do przygotowywania emulsji
JP4269078B2 (ja) * 2002-06-03 2009-05-27 宮崎県 Ｓ／ｏ／ｗエマルション及びその製造方法
JP2005008810A (ja) * 2003-06-20 2005-01-13 Kao Corp 不飽和脂肪酸含有油脂粉末

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935033A (en) * 1970-07-18 1976-01-27 Siemens Aktiengesellschaft Method of improving the radiation resistance of silicon transistors with a silicon oxide coating
US4160850A (en) * 1975-08-25 1979-07-10 General Mills, Inc. Shelf-stable mix for a spreadable butter-substitute
US4200551A (en) * 1978-11-27 1980-04-29 A. E. Staley Manufacturing Company Cold-water-dispersible lecithin concentrates
US4748028A (en) * 1987-02-18 1988-05-31 Borden, Inc. Aseptic fluid coffee whitener and process for preparing same
US4835002A (en) * 1987-07-10 1989-05-30 Wolf Peter A Microemulsions of oil in water and alcohol
US5160759A (en) * 1989-06-07 1992-11-03 Kao Corporation Edible oil-in-water emulsion
US5607622A (en) * 1992-06-29 1997-03-04 Mikimoto Pharmaceutical Co., Ltd. Oil-in-water cream base
US20020106390A1 (en) * 1998-05-11 2002-08-08 Dietmar Huglin Use of nanodispersions in cosmetic end formulations
US20040022861A1 (en) * 2001-01-30 2004-02-05 Williams Robert O. Process for production of nanoparticles and microparticles by spray freezing into liquid
US20040013708A1 (en) * 2002-04-10 2004-01-22 Goulson Melanie J. Aqueous dispersible steryl ester compositions
US20050191343A1 (en) * 2003-11-26 2005-09-01 Shire Laboratories, Inc. Micellar systems useful for delivery of lipophilic or hydrophobic compounds
US20070213234A1 (en) * 2004-05-18 2007-09-13 Nestec S.A. Oil-in-water emulsion for delivery

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Nakajima et al, Human translation of JP 2004008837, original document published Jan. 2004, Japanese Patent, 39 pages. *
Ponginebbi et al, Effect of relative humidity on lipid oxidation in freeze-dried emulsions, 2000, Grasas y Aceites, Vol. 51, Fasc. 5, pages 348-354. *
Sugiura et al, Preparation characteristics of water-in-oil-in-water multiple emulsions using microchannel emulsification, 2004, Jouranl of Colloid and Interface Science, 270, pages 221-228. *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100068105A1 (en) * 2005-04-26 2010-03-18 Aviza Technology Limited Microfluidic structures and how to make them
US20140377435A1 (en) * 2007-12-13 2014-12-25 Cognis Ip Management Gmbh Lipophilic Antioxidant
WO2013060577A1 (en) 2011-10-25 2013-05-02 Unilever N.V. Edible product and use thereof for increasing bioavailability of micronutrients comprised in vegetables or fruit
US11985998B2 (en) 2013-09-13 2024-05-21 N. V. Nutricia Process for preparing infant formula using a static mixer
CN111182883A (zh) * 2017-10-10 2020-05-19 荷兰联合利华有限公司 具有中和的脂肪酸的纳米乳液及其生产方法
US11219581B2 (en) 2017-10-10 2022-01-11 Conopco, Inc. Nanoemulsions with neutralized fatty acid and a method producing the same
US11540984B2 (en) 2018-05-23 2023-01-03 Conopco, Inc. Nanoemulsions and a method for making the same
US20240110099A1 (en) * 2019-10-08 2024-04-04 Kao Corporation Liquid-crystal composition
US12473494B2 (en) * 2019-10-08 2025-11-18 Kao Corporation Liquid-crystal composition
US20220054999A1 (en) * 2020-08-21 2022-02-24 China Research Institute Of Daily Chemistry Co.,Ltd High internal phase emulsion stabilized by low content of surfactant and preparation method thereof
US11879086B2 (en) * 2020-08-21 2024-01-23 China Research Institute Of Daily Chemistry Co., Ltd High internal phase emulsion stabilized by low content of surfactant and preparation method thereof
CN112933043A (zh) * 2021-02-24 2021-06-11 石家庄四药有限公司 一种盐酸阿比多尔注射乳剂及其制备方法

Also Published As

Publication number Publication date
CN101360424A (zh) 2009-02-04
EP1956920A1 (en) 2008-08-20
US20120177708A1 (en) 2012-07-12
IL191373A (en) 2013-01-31
RU2417618C2 (ru) 2011-05-10
CA2629733A1 (en) 2007-05-31
RU2008125095A (ru) 2009-12-27
BRPI0618834A2 (pt) 2011-09-13
CN101360424B (zh) 2013-05-15
US8388985B2 (en) 2013-03-05
WO2007060171A1 (en) 2007-05-31
JP2009523061A (ja) 2009-06-18
AU2006316501A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
US8388985B2 (en) Easily dispersible lipidic phase
US8158687B2 (en) Oil-in-water emulsion for delivery
US8513311B2 (en) Oil-in-water emulsion and its use for the delivery of functionality
US20080299200A1 (en) Oil-in-Water Emulsion for Creating New Product Consistencies
WO2008145183A1 (en) Oil-in-water emulsion and its use for the delayed release of active elements
EP1597973A1 (en) Oil-in-water emulsion for delivery
AU2013206329A1 (en) Easily dispersible lipidic phase

Legal Events

Date Code Title Description
AS Assignment

Owner name: NESTEC S.A., SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LESER, MARTIN;SAGALOWICZ, LAURENT;MICHEL, MARTIN;AND OTHERS;REEL/FRAME:021943/0869;SIGNING DATES FROM 20080821 TO 20081110

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION